Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Journal of Hepatology Année : 2016

Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme

Fichier non déposé

Dates et versions

hal-03590935 , version 1 (28-02-2022)

Identifiants

Citer

V. Leroy, C. Hezode, S. Metivier, M. Tateo, F. Conti, et al.. Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme. Journal of Hepatology, 2016, 64 (2), pp.S829. ⟨10.1016/S0168-8278(16)01622-6⟩. ⟨hal-03590935⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More